HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Endovascular management of takayasu arteritis: is it a durable option?

Abstract
Interim outcome of endovascular management of Takayasu arteritis (TA) was determined retrospectively to assess the efficacy of angioplasty and/or stenting in 24 patients with 35 lesions in the chronic inactive stage. The renal (n=16), subclavian/innominate (n=11), and carotid (n=5) arteries and abdominal aorta (n=3) were treated. Twenty-six lesions achieved excellent to good target lesion revascularization with no residual or only minimal residual stenosis, whereas five had a moderate result. Thirty lesions achieved satisfactory hemodynamic correction. Restenosis was observed in 8 lesions treated with angioplasty alone (n=18) and in 3 lesions treated with angioplasty and stenting (n=17). All recurrent stenoses underwent successful reintervention without significant complication. Treatment of inactive stage TA lesions with angioplasty alone or with angioplasty and stenting results in excellent to good clinical improvement in the majority of patients (follow-up at 46.8 months). Endovascular therapy is a durable treatment option in patients with chronic inactive stage TA.
AuthorsByung-Boong Lee, James Laredo, Richard Neville, J Leonel Villavicencio
JournalVascular (Vascular) Vol. 17 Issue 3 Pg. 138-46 ( 2009) ISSN: 1708-5381 [Print] England
PMID19476746 (Publication Type: Journal Article)
Chemical References
  • Radiopharmaceuticals
  • Gadolinium
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Angioplasty, Balloon, Coronary (methods)
  • Aorta (diagnostic imaging, surgery)
  • Aortography
  • Child
  • Chronic Disease
  • Female
  • Gadolinium (therapeutic use)
  • Humans
  • Magnetic Resonance Angiography
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Patient Selection
  • Radiopharmaceuticals (therapeutic use)
  • Retrospective Studies
  • Stents
  • Takayasu Arteritis (diagnostic imaging, surgery)
  • Treatment Outcome
  • Ultrasonography
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: